HitGen Inc.,
Business Type:Lab/Research institutions
Audited Supplier
- Main Products:
- Year Established:
- 2020
HitGen is a rapidly growing biotech company with headquarters based in Chengdu, China, with a subsidiary in the USA. HitGen has established an industry-leading platform for early-stage drug discovery research centred on DNA encoded chemical libraries (DELs). HitGen’s DELs include encoded syntheses for hundreds of billions of novel, diverse, drug-like small molecule and macrocycle compounds. These compounds are members of DELs synthesised from many hundreds of distinct chemical scaffolds, designe...
MoreCompany Authentication
Time of verification: | 2020-4-26 10:27 | |
Company Name: | HitGen Inc., | |
Country/Territory: | China (Mainland) | |
Registered Address: | Building 6, No.8, Huigu 1st East Road, Tianfu International Bio-Town, Shuangliu District, Chengdu 610200, Sichuan, China | |
Company Scale: |
501 - 1000 | |
Registered Capital: |
360000000 |
|
Business Type: |
True |
|
Business Scope: |
Custom DNA Encoded Library Synthesis; DNA Encoded Libraries Screening; Specialized Chemistry and Bioscience Services: Custom synthesis of biomacromolecule such as RNA/DNA, RNA/DNA modification, RNA/DNA conjugate glycoside and nucleoside compound; Custom synthesis of normal chemical compound with specific structure; Innovative Drug Discovery Project Based Collaboration (Licensing) |
|
Main Markets: |
North America Eastern Europe Southeast Asia Western Europe |
|
Company Corporate Representative: | LI |
Certificate
Business License: |
|
Tax Registration Certificate: |
|
Organization Code Certificate: |
|
Legal person's id card: |